TSHA-102

· Taysha Gene Therapies, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TSHA-102, covering 2025-10-15 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome [Phase 3]

See pricing